Sly syndrome
Sly syndrome | |
---|---|
Other names | β-glucuronidase deficiency, β-glucuronidase deficiency mucopolysaccharidosis, |
Sly syndrome has an autosomal recessive pattern of inheritance. | |
Specialty | Endocrinology |
Sly syndrome, also called
Signs and symptoms
The most severe cases of Sly syndrome can result in
While some individuals have developmental delay, others may have normal intelligence.[1] However, the accumulation of GAGs in the brain usually leads to the slowing of development from ages 1–3, and then a loss of previously learned skills until death.[2]
Genetics
The defective gene responsible for Sly syndrome is located on chromosome 7.[3]
Diagnosis
Most people with Sly disease will have elevated levels of GAGs seen in the urine. A confirmatory test is necessary for diagnosis. Skin cells and red blood cells of affected people will have low levels of β-glucuronidase activity. Sly syndrome can also be diagnosed through prenatal testing.[2]
Treatment
Prognosis
The life expectancy of individuals with MPS VII varies depending on the symptoms. Some individuals are stillborn, while some may survive into adulthood.[1]
Epidemiology
MPS-VII is one of the rarest forms of MPS. It occurs in less than 1 in 250,000 births. As a family, MPS diseases occur in 1 in 25,000 births, and the larger family of lysosomal storage diseases occur in 1 out of 7,000 to 8,000 births.[2]
History
Sly syndrome was originally discovered in 1972.[2] It was named after its discoverer William S. Sly, an American biochemist who has spent nearly his entire academic career at Saint Louis University.[5][6]
References
- ^ a b c d "Mucopolysaccharidosis type VII". United States National Library of Medicine. 25 June 2019. Retrieved 2 July 2019.
- ^ a b c d e "A Guide to Understanding MPS VII" (PDF). National MPS Society. Retrieved 2 July 2019.
- PMID 3376995.
- PMID 30848434.
- ^ "slu.edu". Archived from the original on 2007-09-11. Retrieved 2007-12-31.
- PMID 4265197.